OptimizeRx Corp Quarterly Income Tax Expense (Benefit) in USD from Q2 2023 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
OptimizeRx Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2023 to Q2 2024.
- OptimizeRx Corp Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$1.09M, a 3397% decline year-over-year.
- OptimizeRx Corp annual Income Tax Expense (Benefit) for 2023 was -$7.6M.
- OptimizeRx Corp annual Income Tax Expense (Benefit) for 2019 was -$898K.
- OptimizeRx Corp annual Income Tax Expense (Benefit) for 2015 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)